For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210610:nBwbKr5Xka&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 09 June 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,877,144 1.46% 230,795 0.18%
(2) Derivatives (other than options):
72,359 0.06% 94,581 0.07%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,955,603 1.52% 331,476 0.26%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 13 254.5700 USD
Purchase 20 253.1800 USD
Purchase 100 253.4900 USD
Purchase 100 253.4200 USD
Purchase 100 253.1940 USD
Purchase 154 254.4165 USD
Purchase 180 253.8983 USD
Purchase 200 253.6200 USD
Purchase 200 253.6500 USD
Purchase 200 253.6950 USD
Purchase 234 253.7775 USD
Purchase 267 253.7314 USD
Purchase 289 253.7167 USD
Purchase 300 253.5000 USD
Purchase 308 254.9775 USD
Purchase 367 253.8022 USD
Purchase 600 253.6300 USD
Purchase 600 253.7000 USD
Purchase 672 253.8391 USD
Purchase 936 253.8801 USD
Purchase 2,800 254.2737 USD
Purchase 3,449 254.1284 USD
Purchase 3,715 254.5099 USD
Purchase 4,109 254.7792 USD
Purchase 4,532 254.0140 USD
Purchase 4,966 253.7199 USD
Purchase 9,076 254.5100 USD
Purchase 10,733 253.9705 USD
Purchase 23,133 254.1759 USD
Purchase 30,000 253.6619 USD
Sale 89 253.5300 USD
Sale 100 253.7900 USD
Sale 100 255.2200 USD
Sale 117 254.5379 USD
Sale 154 254.4165 USD
Sale 207 254.3511 USD
Sale 210 253.2266 USD
Sale 369 253.7478 USD
Sale 580 254.7339 USD
Sale 830 253.9381 USD
Sale 887 253.7851 USD
Sale 1,030 253.5308 USD
Sale 1,071 253.8155 USD
Sale 1,101 253.8176 USD
Sale 1,877 253.7237 USD
Sale 2,746 254.5100 USD
Sale 3,578 254.3137 USD
Sale 3,715 254.5099 USD
Sale 3,952 253.9084 USD
Sale 4,010 254.8302 USD
Sale 4,521 254.0230 USD
Sale 9,509 253.6519 USD
Sale 9,752 254.2001 USD
Sale 12,164 253.7462 USD
Sale 18,200 253.8599 USD
Sale 21,167 254.1259 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 10 Jun 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210610005509/en/
(https://www.businesswire.com/news/home/20210610005509/en/)
BARCLAYS PLC
Copyright Business Wire 2021